Home / Facilities / 3001581899

Contract Pharmaceuticals Limited Canada FDA Inspection Record

FEI 3001581899 · Inspections, Form 483s, warning letters and import refusals

Contract Pharmaceuticals Limited Canada is an FDA-registered facility (FEI 3001581899) located in Mississauga, CA. Registered operations: LABEL; MANUFACTURE; PACK. RegDataLab tracks 6 FDA inspections at this facility.

What FDA found at this site

Latest inspection
Nov 3, 2023: Voluntary Action Indicated (VAI)
Inspections on record
6 (4 VAI, 2 NAI)
Last OAI inspection
None on record
Warning letters
None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
Form 483 and inspection documents
1 in FDA's reading room
Recalls as the recalling firm
2, latest Feb 20, 2024
Import refusals
10 or more

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Nov 3, 2023Voluntary Action Indicated (VAI)Investigations of discrepancies, failures (21 CFR 211.192)
May 17, 2019Voluntary Action Indicated (VAI)Extent of discrepancy, failure investigations (21 CFR 211.192)
Mar 31, 2017No Action Indicated (NAI)No citations listed
Apr 11, 2014Voluntary Action Indicated (VAI)No citations listed
Feb 24, 2012Voluntary Action Indicated (VAI)No citations listed
Sep 3, 2009No Action Indicated (NAI)No citations listed

Recalls

Newest first. Recalls FDA's Enforcement Report lists with this FEI as the recalling firm. The recalling firm is not always the site that made the product. Search FDA's Enforcement Report by recall number.

DateClassRecallProduct and reason
Feb 20, 2024Class IIID-0364-2024Clindamycin Phosphate, Topical Solution USP, 1%, 60 mL, Rx Only, Manufactured for and… and 1 more product
Defective Container: Out of specification for weight due to a slow leakage at the 12-month stability timepoint.
Aug 23, 2023Class IIID-1139-2023Clindamycin Phosphate Topical Solution USP, 1%, 60 mL bottle, Rx only, Manufactured by…
Defective Container: slow leakage under the cap

Form 483s and inspection documents

  • 483 on FDA.gov
    Inspection Oct 30, 2023 to Nov 3, 2023, issued Nov 3, 2023 (dates printed on the document). FDA listing date Nov 3, 2023. Published by FDA Apr 3, 2024.

FDA record score

5 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.

Counted on Nov 14, 2026, method version 1. It counts records and does not judge the site: a low number does not establish that a site is safe, and sites that FDA inspects more often can collect more points. How this is counted.

4 records behind this number
RecordDatePoints x age weightAdds
Inspection classified VAINov 3, 20236 x 0.63.6
Inspection classified VAIMay 17, 20196 x 0.251.5
Inspection classified VAIApr 11, 201410 years or older, so it adds no points0
Inspection classified VAIFeb 24, 201210 years or older, so it adds no points0

When each source was last refreshed

FDA sources behind this page and when RegDataLab last refreshed each one
RecordsLast refreshedSource as ofStatus
InspectionsNov 14, 2026Newest record Nov 5, 2026Current
Inspection citationsNov 14, 2026Newest record Nov 5, 2026Current
Compliance actions (warning letters, injunctions and other action types)Nov 2, 2026Newest record Oct 29, 2026Current
Warning letter textNov 14, 2026Newest record Nov 10, 2026Current
Recalls (Enforcement Report)Nov 14, 2026Newest record Nov 11, 2026Current
Form 483s and inspection documentsNov 13, 2026Newest record Nov 12, 2026Current
Import refusalsNov 2, 2026Newest record Oct 22, 2026Current

Reviewing Contract Pharmaceuticals Limited Canada as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Contract Pharmaceuticals Limited Canada yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Facility details

Company
Contract Pharmaceuticals Limited Canada
Location
Mississauga (CA)
Registration Expires
Dec 31, 2026
Operations
LABEL; MANUFACTURE; PACK
Source
decrs

Import refusals

FDA data resources

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.